Functional degradation: A mechanism of NLRP1 inflammasome activation by diverse pathogen enzymes.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 30872533.
- Also identified by DOI 10.1126/science.aau1330 and PMC identifier 6532986.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Inflammasomes are multiprotein platforms that initiate innate immunity by recruitment and activation of caspase-1. The NLRP1B inflammasome is activated upon direct cleavage by the anthrax lethal toxin protease. However, the mechanism by which cleavage results in NLRP1B activation is unknown. In this study, we find that cleavage results in proteasome-mediated degradation of the amino-terminal domains of NLRP1B, liberating a carboxyl-terminal fragment that is a potent caspase-1 activator. Proteasome-mediated degradation of NLRP1B is both necessary and sufficient for NLRP1B activation. Consistent with our functional degradation model, we identify IpaH7.8, a <i>Shigella flexneri</i> ubiquitin ligase secreted effector, as an enzyme that induces NLRP1B degradation and activation. Our results provide a unified mechanism for NLRP1B activation by diverse pathogen-encoded enzymatic activities.
Medical subject headings
- Adaptor Proteins, Signal Transducing
- Antigens, Bacterial
- Apoptosis Regulatory Proteins
- Bacterial Proteins
- Host-Pathogen Interactions
- Immunity, Innate
- Inflammasomes
- Peptide Hydrolases
- Proteolysis
- Shigella flexneri
- Ubiquitin-Protein Ligases